IL130376A0 - Spiro¬piperidine-4,1'-pyrrolo¬3,4-c¾pyrrole¾ - Google Patents

Spiro¬piperidine-4,1'-pyrrolo¬3,4-c¾pyrrole¾

Info

Publication number
IL130376A0
IL130376A0 IL13037699A IL13037699A IL130376A0 IL 130376 A0 IL130376 A0 IL 130376A0 IL 13037699 A IL13037699 A IL 13037699A IL 13037699 A IL13037699 A IL 13037699A IL 130376 A0 IL130376 A0 IL 130376A0
Authority
IL
Israel
Prior art keywords
pyrrolo
spiro
piperidine
Prior art date
Application number
IL13037699A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL130376A0 publication Critical patent/IL130376A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL13037699A 1998-06-12 1999-06-09 Spiro¬piperidine-4,1'-pyrrolo¬3,4-c¾pyrrole¾ IL130376A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98110803 1998-06-12
EP98124119 1998-12-18

Publications (1)

Publication Number Publication Date
IL130376A0 true IL130376A0 (en) 2000-06-01

Family

ID=26149342

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13037699A IL130376A0 (en) 1998-06-12 1999-06-09 Spiro¬piperidine-4,1'-pyrrolo¬3,4-c¾pyrrole¾

Country Status (27)

Country Link
US (1) US6075034A (ko)
EP (1) EP0963987B1 (ko)
JP (1) JP3308507B2 (ko)
KR (1) KR100346607B1 (ko)
AR (1) AR018650A1 (ko)
AT (1) ATE222908T1 (ko)
AU (1) AU749995B2 (ko)
BR (1) BR9902245A (ko)
CA (1) CA2274204C (ko)
CO (1) CO5060459A1 (ko)
DE (1) DE69902606T2 (ko)
DK (1) DK0963987T3 (ko)
ES (1) ES2181336T3 (ko)
HR (1) HRP990189A2 (ko)
HU (1) HUP9901909A3 (ko)
ID (1) ID23283A (ko)
IL (1) IL130376A0 (ko)
MA (1) MA26643A1 (ko)
NO (1) NO312069B1 (ko)
NZ (1) NZ336186A (ko)
PE (1) PE20000549A1 (ko)
PL (1) PL333694A1 (ko)
PT (1) PT963987E (ko)
SG (1) SG76623A1 (ko)
TR (1) TR199901304A3 (ko)
TW (1) TW523516B (ko)
YU (1) YU26599A (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4155029B2 (ja) 2000-11-15 2008-09-24 萬有製薬株式会社 ベンズイミダゾール誘導体
CA2490386A1 (en) * 2001-07-02 2003-01-16 Omeros Corporation Method for producing analgesia comprising administration of an opioid receptor agonist in rotation with an opioid receptor like-1 receptor agonist
US20030040479A1 (en) * 2001-07-02 2003-02-27 Omeros Corporation Rotational intrathecal analgesia method and device
JP2005289816A (ja) 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
ZA200510329B (en) * 2003-05-23 2007-04-25 Zealand Pharma As Triaza-spiro compounds as nociceptin analogues and uses thereof
US20050228023A1 (en) * 2003-12-19 2005-10-13 Sri International Agonist and antagonist ligands of the nociceptin receptor
JP4446978B2 (ja) * 2006-04-28 2010-04-07 トヨタ自動車株式会社 車両用駆動力制御装置
EP2128154B1 (en) * 2007-03-01 2015-04-08 Mitsubishi Tanabe Pharma Corporation Benzimidazole compound and pharmaceutical use thereof
KR101561666B1 (ko) 2014-08-12 2015-10-20 최인석 골프 퍼팅 교정장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Also Published As

Publication number Publication date
AU749995B2 (en) 2002-07-04
NO992872L (no) 1999-12-13
TR199901304A2 (xx) 2000-01-21
JP2000053680A (ja) 2000-02-22
AU3500399A (en) 1999-12-23
HRP990189A2 (en) 2000-02-29
NO312069B1 (no) 2002-03-11
TR199901304A3 (tr) 2000-01-21
JP3308507B2 (ja) 2002-07-29
NZ336186A (en) 2000-10-27
PE20000549A1 (es) 2000-07-24
US6075034A (en) 2000-06-13
KR100346607B1 (ko) 2002-08-07
DE69902606D1 (de) 2002-10-02
PL333694A1 (en) 1999-12-20
HU9901909D0 (en) 1999-08-30
HUP9901909A2 (hu) 2000-04-28
KR20000006079A (ko) 2000-01-25
EP0963987A2 (en) 1999-12-15
EP0963987B1 (en) 2002-08-28
YU26599A (sh) 2002-09-19
TW523516B (en) 2003-03-11
DK0963987T3 (da) 2002-12-30
AR018650A1 (es) 2001-11-28
SG76623A1 (en) 2000-11-21
BR9902245A (pt) 2000-03-21
ATE222908T1 (de) 2002-09-15
CO5060459A1 (es) 2001-07-30
CA2274204C (en) 2009-09-15
MA26643A1 (fr) 2004-12-20
DE69902606T2 (de) 2003-04-24
HUP9901909A3 (en) 2001-11-28
EP0963987A3 (en) 2001-01-17
CA2274204A1 (en) 1999-12-12
ES2181336T3 (es) 2003-02-16
NO992872D0 (no) 1999-06-11
PT963987E (pt) 2003-01-31
ID23283A (id) 2000-04-05

Similar Documents

Publication Publication Date Title
HU9800138D0 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
HU9501600D0 (en) Thieno[1,5]benzodiazepine use
AP9901583A0 (en) Pyrrolo[2,3-d] pirimidine compounds
PL353827A1 (en) 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i
ZA989210B (en) Macrocycles
IL127399A0 (en) 1,3,8-Triaza-spiro (4,5) decan-4-on derivatives
PL353366A1 (en) Pyrazolo[4,3-d]pyrimidines
SG79259A1 (en) Diaza-spiro[3,5]nonane deravatives
PL349341A1 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives
IL130376A0 (en) Spiro¬piperidine-4,1'-pyrrolo¬3,4-c¾pyrrole¾
IL135982A0 (en) Fungicidal combinations comprising thieno[2,3-d]pyrimidin-4-one
PL347493A1 (en) Fungicidal combinations comprising thieno[2,3-d]pyrimidin-4-one
ZA993853B (en) Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole].
SG70655A1 (en) New spirocyclic compounds
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
PL356668A1 (en) Novel substituted pyrazolo[4,3-e
IL149051A0 (en) Pyrazolo [1,5,-d] [1,2,4] triazines for enhancing cognition
ZA972984B (en) Spiro[cyclopent[b]indole-piperidines.
ZA988270B (en) Preparation with dispensing means
TW414085U (en) Safety injector
IL127658A0 (en) Interconnect design with controlled inductance
GB2341333B (en) Design for fun fair ride
GB9704706D0 (en) Beverage preparation
PL352760A1 (en) Oxathiepino[6,5-b
TW344384U (en) Coloring cup structure